{"id":"W4388930229","doi":"10.2196/46709","title":"Efficacy and Safety of the Natural Killer T Cell–Stimulatory Glycolipid OCH-NCNP1 for Patients With Relapsing Multiple Sclerosis: Protocol for a Randomized Placebo-Controlled Clinical Trial","year":2023,"lang":"en","type":"article","venue":"JMIR Research Protocols","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"EA Pharma Co., Ltd.","keywords":"Medicine; Protocol (science); Randomized controlled trial; Multiple sclerosis; Placebo; Clinical trial; Preprint; Pharmacology; Alternative medicine; Immunology; Internal medicine; Computer science; Pathology; World Wide Web","routes":{"ca_aff":false,"ca_fund":false,"ca_venue":true,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.01795273,0.005374408,0.008256716,0.001728261,0.00283451,0.002509713,0.003216186,0.005960388,0.0297168],"category_scores_gemma":[0.01395054,0.002272286,0.003420631,0.001703103,0.003372756,0.002512711,0.001383695,0.005935634,0.005588746],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002845778,"about_ca_system_score_gemma":0.009820699,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001206652,"about_ca_topic_score_gemma":0.002509141,"domain_scores_codex":[0.9892364,0.006575607,0.001011409,0.001030509,0.0009824585,0.001163565],"domain_scores_gemma":[0.9916732,0.001601037,0.001855408,0.001121347,0.001756993,0.001992072],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9718351,0.01182598,0.0002851314,0.00193556,0.000450021,0.00006900541,0.00008527919,0.000486848,0.001871601,0.0004882014,0.002456318,0.008210916],"study_design_scores_gemma":[0.9652376,0.02853344,0.0004801182,0.0001806733,0.0002427486,0.00002147824,0.00002198029,0.0003722257,0.0003329945,0.000297818,0.004251172,0.00002771476],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"protocol","genre_gemma":"protocol","genre_scores_codex":[0.01975714,0.000680123,0.00176599,0.0005191035,0.0006237788,0.9731732,0.001553305,0.000167514,0.00175969],"genre_scores_gemma":[0.02221386,0.0005440898,0.004259498,0.0007398012,0.0002764575,0.9699336,0.0005756055,0.00001563646,0.001441404],"genre_candidate":"protocol","genre_consensus":"protocol","teacher_disagreement_score":0.0297168,"threshold_uncertainty_score":0.09941256,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2496151261271388,"score_gpt":0.5188293551999238,"score_spread":0.2692142290727849,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}